本站原创「海峡两岸论文」摘 要投稿规则及流程说明
一、截止日期为2016年2月28日.
二、已在其他期刊发表过的文章,恕不采用.
三、投稿摘 要内容格式:(请依照下列格式缮打成Word档案)
摘 要题目,作者,服务单位均为中英文对照,内文一律为英文.
内文顺序应包含:Purpose,Materials&,Methods,Results,Conclusion等四项.
字体:中文字体请使用【标楷体】,英文字体请使用【TimesNewRoman】
中英文题目请以【14号粗体】字,其余请以【12号】字缮打.
行距-最小行高,行高-12,文件格线被设定时,贴齐栏位勿打勾.
英文篇名每字字首均统一使用大写.
第一作者请在姓名下方用下底线注明,不同服务单位请用数字1,2,3上标注明.
版面设定:每篇论文(含题目,作者,服务单位,内文)以一张A4满页为限,
上下左右各预留3公分装订边距离.
四、投稿分类:(请务必勾选类别)
性质:□基础,□转译,□临床
分类:1.TumorBiologyandBasicResearch
2.Epidemiology,Pathology,andDiagnosis
3.ClinicalTrial/Chemotherapy
4.ClinicalTrial/CombinedModalityandRadiotherapy
5.RadiationPhysics
6.ClinicalTrial/CombinedModalityandSurgicalOncology
7.Prognosis,Survival,andTreatmentRelatedComplications
8.CaseReportandMiscellaneous
五、论文摘 要档案请务必使用MicrosoftWord存档.
六、投稿论文将刊登於大会会刊.
七、上传论文摘 要内容范例:
1.中文题目→
2.英文题目→
3.中文姓名→
4.英文姓名→
5.中文服务单位→
6.英文服务单位→
7.摘 要内容顺序:→
(一律用英文,分四段落撰写)
→
→
→
胚胎绒毛抗原(CEA)比细胞激素对区别良性与恶性肋膜积水的监别诊断有所助益
CEAisMoreUsefulthanCytokinesintheDifferentialDiagnosisDistinguishingMalignantPleuralEffusionfromBenignConditions
阳光耀1陈育民1蔡俊明1彭瑞鹏1
Kuang-YaoYang,M.D.,Yuh-MinChen,M.D.,Ph.D.,Chun-MingTsai,M.D.,Ph.D.,Reury-PerngPerng,M.D.,Ph.D.
行政院退辅会台北荣民总医院胸腔部1
TaipeiVeteransGeneralHospital,ChestDepartment
Purpose:
Weinvestigatedtheroleofcytokines[tumornecrosiactor-a(TNF-a),interleukin-1b(IL-1b),macrophageinflammatoryproteins1b(MIP-1b),granulocyte-macrophagecolonystimulatingfactor(GM-C),IL-15]intheevaluationofpleuraleffusionetiology.
Methods:
Usingmercially-ailableELISAkits,concentrationsofthesecytokinesweremeasuredinthepleuralfluidandperipheralbloodofpatientswithmalignanteffusions(n等于51),parapneumoniceffusions(n等于7),tuberculouspleurisy(n等于8),andtransudative(n等于8)effusionsduetocongestiveheartfailureorlivercirrhosis.Carcinoembryonicantigen(CEA)levelswerealsocheckedandusedforparison.
Results:
Theresultsshowedthat75%ofbloodTNF-aand50%ofeffusionTNF-a,90%ofbloodIL-1band67.5%ofeffusionIL-1b,and97.5%ofbloodGM-Cand55%ofeffusionGM-C,werebelowminimaldetectableconcentrations,while92.5%ofbloodIL-15and100%ofeffusionIL-15,and95%ofbloodMIP-1band92.5%ofeffusionMIP-1b,weredetectable.Therewasnosignificantdifferenceincytokinelevelsamongasubgroupofpatientswithbenignpleuraleffusion,ineitherthepleuralfluidorperipheralblood,however,thepleuralfluidTNF-aandIL-15levelswerehigherinTBpleurisy(p等于0.048and0.045,respectively),andbloodMIP-1blevelswerelowerinpatientswithtransudates.Ingeneral,thepleuralfluidcytokinelevelswerehigherthanthebloodlevels,iftheyweredetectable,inboththebenignandmalignanteffusions.However,MIP-1bwashigherintheperipheralbloodthaninthepleuralfluidinpatientswithmalignanteffusion(p等于0.009).Noneofthesecytokinescouldbeusedforthedifferentialdiagnosisofbenignandmalignantpleuraleffusion(p>,0.05),ineitherthepleuralfluidortheperipheralblood,exceptforpleuralfluidTNF-a,whichwasrelativelyhigherinbenigndisease(p等于0.028).Ontheotherhand,thereweresignificantdifferencesintheCEAlevelsintheperipheralblood(p等于0.012)andpleuralfluid(p等于0.001)ofbenignandmalignantdiseases.
Conclusions:
ThesefindingssuggestthatpleuralfluidCEAlevelsarestillbetterthancytokineorthedifferentialdiagnosisofbenignandmalignantpleuraleffusion.
第十四届海峡两岸肿瘤学术会议论文投稿ABSTRACT
性质:□基础□转译□临床
□转译
□临床
分类编号:
收件编号:
第一作者中文姓名:传真::手机:E-mail: